| Patient | Alexander the Great |
|---|---|
| Date of birth | 1993-07-20 |
| Identifiers | MRN HR-AC002-SYN; SSN (made up) 000-02-3567 |
| Document date | 2026-05-11 |
| Author | Theodora Papadakis-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Nine-week review. [S]
Alexander runs again and marches a full day with his kit; he is short of breath only at the top of long climbs. The scar aches at 2 of 10 after heavy training, and he uses the lidocaine patch three or four nights a week. He has kept to his drinking limits at every banquet in the past three weeks and has had no alcohol on most days. He sees the addiction medicine and behavioral health clinicians every two weeks. He sleeps six to seven hours and says the grief is still there but no longer runs his days. His HIV, hepatitis C and hepatitis B tests from the preventive visit were negative, with immunity to hepatitis B from his childhood vaccines. He is planning the next campaign. [S]
| Element | Detail |
|---|---|
| Spirometry | FVC 4.14 L (83 percent predicted); FEV1 3.46 L (83 percent); ratio 0.84 |
| Chest wall pain | 2 of 10 after heavy training |
| Alcohol | Within his goal for three weeks; PEth 31 ng/mL; AUDIT-C 3 |
| Mood | PHQ-9 5, item 9 scored 0 |
| Screening | HIV, hepatitis C and hepatitis B negative; hepatitis B immune |
| System | Result | Finding |
|---|---|---|
| Respiratory | Positive | Short of breath only at the top of long climbs |
| Musculoskeletal | Positive | Scar ache 2 of 10 after training |
| Constitutional | Negative | Energy good; no fevers |
| Psychiatric | Negative | Mood steadier; no thoughts of self-harm |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Acetaminophen 500 mg oral tablet, one or two tablets up to four times a day as needed for chest wall pain, no more than 2,000 mg in a day while he is drinking heavily | One to two tablets by mouth every six hours as needed; no more than four tablets a day | Oral route | 2026-03-09 | active | S |
| Thiamine 100 mg oral tablet once daily for three months | One tablet by mouth daily | Oral route | 2026-03-09 | active | S |
| Lidocaine 5% medicated patch, one patch over the painful scar for up to 12 hours in each 24 hours | Apply one patch to the painful area for up to 12 hours, then remove for 12 hours | Topical route | 2026-03-23 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-05-11 | Body height | 170 | cm | S |
| 2026-05-11 | Body weight | 71.5 | kg | S |
| 2026-05-11 | Body mass index (BMI) [Ratio] | 24.7 | kg/m2 | S |
| 2026-05-11 | Systolic blood pressure | 120 | mm[Hg] | S |
| 2026-05-11 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2026-05-11 | Heart rate | 66 | /min | S |
| 2026-05-11 | Respiratory rate | 14 | /min | S |
| 2026-05-11 | Body temperature | 36.6 | Cel | S |
| 2026-05-11 | Oxygen saturation in Arterial blood by Pulse oximetry | 99 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-05-11 | Forced vital capacity [Volume] Respiratory system | 4.14 | L | Lower limit of normal for his age and height (GLI 2012); predicted 5.00 L | Normal | S |
| 2026-05-11 | FVC measured/predicted | 83 | % | >=80% | Normal | S |
| 2026-05-11 | FEV1 | 3.46 | L | Lower limit of normal for his age and height (GLI 2012); predicted 4.15 L | Normal | S |
| 2026-05-11 | FEV1 measured/predicted | 83 | % | >=80% | Normal | S |
| 2026-05-11 | FEV1/FVC | 0.84 | {ratio} | Lower limit of normal for his age (GLI 2012) | Normal | S |
| 2026-05-11 | Phosphatidylethanol [Mass/volume] in Blood | 31 | ng/mL | Below 20 ng/mL abstinence or light drinking; 20 to 200 significant drinking; above 200 heavy drinking | High | S |
| 2026-05-11 | Total score [AUDIT-C] | 3 | {score} | S | ||
| 2026-05-11 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 5 | {score} | S | ||
| 2026-05-11 | Pain severity - 0-10 verbal numeric rating [Score] - Reported | 2 | {score} | S |
Vital signs recorded on 2026-05-11; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 120/76, pulse 66; weight 71.5 kg |
| Respiratory | Slightly reduced breath sounds at the left base, unchanged; no crackles |
| Musculoskeletal | Minimal tenderness over the left fifth rib; no allodynia |
| Psychiatric | Bright and engaged; no thoughts of suicide |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Left chest wall pain at the scar of an old penetrating arrow wound, with breathlessness on exertion and a reduced FVC (78 percent predicted) with a normal FEV1/FVC ratio, and heavy episodic drinking (AUDIT 19, PEth 236 ng/mL), found at intake; cause and extent under evaluation with a pulmonology consultation and an addiction medicine assessment | resolved | confirmed | R07.89 | S — Synthetic presenting problem anchored to the documented chest wound and the documented drinking parties; superseded at the consultation, when the chest wall pain, the pleural thickening and the alcohol use disorder were diagnosed. |
| Chronic post-traumatic chest wall pain: intercostal neuropathic pain at the healed left chest wound and fifth rib fracture, with tenderness and a small area of allodynia over the scar | active | confirmed | G89.21 | S — Synthetic modern diagnosis made at the consultation, anchored to the documented arrow wound; not a claim about his real chest. |
| Localized left pleural thickening (fibrothorax) from an old organized hemothorax after a penetrating chest wound, with a mild restrictive defect (TLC 79 percent predicted) and normal gas transfer; no retained foreign body, fistula or trapped lung on CT | active | confirmed | J94.1 | S — Synthetic modern finding of the CT and lung function tests at the consultation, anchored to the documented arrow wound; the retrospective pneumothorax (CLM-0004) is not used. |
| Alcohol use disorder, mild (three DSM-5-TR criteria): drinking more than intended at banquets, riding after drinking, and arguments with his officers while drunk; ten or more drinks on two or three nights a week, more since his bereavement; no withdrawal; AUDIT 19; PEth 236 ng/mL | active | confirmed | F10.10 | S — Synthetic modern diagnosis made with the addiction medicine clinician at the consultation visit, anchored to the documented drinking parties; the criteria, amounts and scores are synthetic. The diagnosis is mild, in keeping with the disputed evidence (CLM-0008). |
| Bereavement five months after the death of his closest companion since boyhood, with depressive symptoms (PHQ-9 12, item 9 scored 0) that do not meet criteria for a major depressive episode; prolonged grief disorder cannot be diagnosed before twelve months | active | confirmed | Z63.4 | S — Synthetic modern assessment anchored to the documented bereavement; DSM-5-TR codes uncomplicated bereavement as Z63.4 whatever the relationship. Not a claim about his real mental health. |
| Laceration of the left forearm, 4 cm, from a practice blade in a training drill; clean edges, no tendon, nerve or vessel injury; repaired with sutures; healed | resolved | confirmed | S51.812A | S — Synthetic acute injury; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Chest wall pain score (0 to 10) and examination of the scar and ribs | Every visit | Completed today | 2 of 10; minimal tenderness; no allodynia |
| Imaging | Spirometry (ATS/ERS 2019 quality) | At diagnosis, and two to three months into the exercise program | Completed today | FVC 4.14 L, 83 percent; FEV1 3.46 L, 83 percent; ratio 0.84 |
| Medication safety | Lidocaine patch: effect and skin check | As needed | Completed today | Three or four nights a week; no skin irritation |
| Medication safety | Analgesic safety: acetaminophen limit; no opioids, tramadol, gabapentinoids or benzodiazepines | Every visit | Completed today | No opioid or sedating medicine |
| Self-management | Physical therapy and the breathing and exercise program | Home exercises daily | Completed today | Running and marching again |
| Survey | Drinking since the last visit (self-report against his goal) | Every visit | Completed today | Within his goal for three weeks |
| Laboratory | PEth | At baseline and every four to six weeks while drinking is changing | Completed today | 31 ng/mL |
| Survey | AUDIT-C | At about two to three months | Completed today | 3, answered for the weeks since intake |
| Laboratory | Liver tests (AST, ALT, GGT) | At baseline and four to six weeks later | Up to date | Normal at six weeks |
| Referral | Sessions with the addiction medicine clinician | Every two weeks, then every four | Completed today | Five sessions; every four weeks from now |
| Survey | PHQ-9 (item 9 reviewed) | At intake, then every four to six weeks while symptoms are active (no antidepressant) | Completed today | 5, from 12; item 9 scored 0 |
| Survey | Grief review (prolonged grief disorder not diagnosable before twelve months) | At each mood review | Completed today | Grief present but no longer disabling |
| Referral | Sessions with the behavioral health clinician | Every two weeks, then every four | Completed today | Five sessions; every four weeks from now |
| Survey | Suicide-risk review, lethal means, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or self-harm; pistol in the armory off duty; 988 card carried |
| Medication safety | Thiamine | Daily for three months | Completed today | To finish in four weeks |
Goal progress:
Guideline basis: Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement (2019); ERS/ATS technical standard on interpretive strategies for routine lung function tests (2022); British Thoracic Society Guideline for pleural disease (2023); CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022 (2022); Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions (2018); VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); CMID: Clinical Monitoring Intelligence Database, depression monograph (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Primary care in three months with PEth and PHQ-9, or sooner for more breathlessness or chest pain. Pulmonology review in a year with spirometry. Addiction medicine and behavioral health every four weeks. The clinic or 988 at any hour. [S]